The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family
The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family
The urocortins are members of the corticotropin releasing hormone (CRH) family of peptide hormones. The archetypal member of this family, CRH, plays an important role in regulating
thermogenesis and homeostasis by acting centrally and systemically in target organs via its two receptors CRH-R1 and CRH-R2. However, by virtue of their much greater relative affinity
for CRH-R2, the physiological effects of the urocortin peptides are largely restricted to peripheral organs such as the heart. A powerful cytoprotective effect of urocortin peptide administration against ischemia and reperfusion injury has been demonstrated in isolated cardiomyocyte models, as well as in the intact heart both in vitro and in vivo. Extremely promising data has shown the beneficial effect of treating pacing-induced heart failure in
sheep with urocortin molecules. Though the efficacy and specificity of these molecules in humans is not yet established, molecular dissection of the cytoprotective pathways activated
by urocortin peptides suggests that the beneficial effects may be separable from potentially deleterious effects.
urocortin, cardiovascular, cardioprotection, heart failure, ischemia and reperfusion
141-150
Davidson, Sean M.
b8eeed87-5d86-42ca-8844-25bf6887253c
Rybka, Aneta E.
cd727133-1dd8-4784-b5b0-ac8f44e52920
Townsend, Paul A.
a2680443-664e-46d0-b4dd-97456ba810db
15 January 2009
Davidson, Sean M.
b8eeed87-5d86-42ca-8844-25bf6887253c
Rybka, Aneta E.
cd727133-1dd8-4784-b5b0-ac8f44e52920
Townsend, Paul A.
a2680443-664e-46d0-b4dd-97456ba810db
Davidson, Sean M., Rybka, Aneta E. and Townsend, Paul A.
(2009)
The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family.
Biochemical Pharmacology, 77 (2), .
(doi:10.1016/j.bcp.2008.08.033).
Abstract
The urocortins are members of the corticotropin releasing hormone (CRH) family of peptide hormones. The archetypal member of this family, CRH, plays an important role in regulating
thermogenesis and homeostasis by acting centrally and systemically in target organs via its two receptors CRH-R1 and CRH-R2. However, by virtue of their much greater relative affinity
for CRH-R2, the physiological effects of the urocortin peptides are largely restricted to peripheral organs such as the heart. A powerful cytoprotective effect of urocortin peptide administration against ischemia and reperfusion injury has been demonstrated in isolated cardiomyocyte models, as well as in the intact heart both in vitro and in vivo. Extremely promising data has shown the beneficial effect of treating pacing-induced heart failure in
sheep with urocortin molecules. Though the efficacy and specificity of these molecules in humans is not yet established, molecular dissection of the cytoprotective pathways activated
by urocortin peptides suggests that the beneficial effects may be separable from potentially deleterious effects.
This record has no associated files available for download.
More information
Published date: 15 January 2009
Keywords:
urocortin, cardiovascular, cardioprotection, heart failure, ischemia and reperfusion
Identifiers
Local EPrints ID: 69622
URI: http://eprints.soton.ac.uk/id/eprint/69622
ISSN: 0006-2952
PURE UUID: e3b3b312-d3dc-4964-bfef-9b75142c7395
Catalogue record
Date deposited: 19 Nov 2009
Last modified: 13 Mar 2024 19:37
Export record
Altmetrics
Contributors
Author:
Sean M. Davidson
Author:
Aneta E. Rybka
Author:
Paul A. Townsend
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics